The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice
- 28 June 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (29) , 3897-3905
- https://doi.org/10.1038/sj.onc.1204519
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 50 references indexed in Scilit:
- p300 functions as a transcriptional coactivator for the TAL1/SCL oncoproteinOncogene, 1999
- The T Cell Leukemia Oncoprotein SCL/tal-1 Is Essential for Development of All Hematopoietic LineagesCell, 1996
- Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis.The Journal of cell biology, 1996
- Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCLNature, 1995
- The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid developmentCell, 1994
- Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivoCell, 1991
- The MyoD DNA binding domain contains a recognition code for muscle-specific gene activationCell, 1990
- Two Distinct Transcription Factors that Bind the Immunoglobulin Enhancer μE5/κE2 MotifScience, 1990
- Mouse T cell antigen receptor: Structure and organization of constant and joining gene segments encoding the β polypeptideCell, 1984
- Two mRNAs can be produced from a single immunoglobulin μ gene by alternative RNA processing pathwaysCell, 1980